| 1 |
34310368 |
10.1097/PAS.0000000000001785 |
2022 |
Reactive Intralymphovascular Immunoblastic Proliferations Mimicking Aggressive Lymphomas. |
IRF4 |
| 2 |
34560683 |
10.1097/PAS.0000000000001813 |
2022 |
A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients. |
IRF4 |
| 3 |
34622970 |
10.1111/cup.14147 |
2022 |
Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites. |
IRF4 |
| 4 |
34654055 |
10.1182/bloodadvances.2021006034 |
2022 |
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements. |
IRF4 |
| 5 |
34699105 |
10.1111/cup.14156 |
2022 |
Patch/plaque mycosis-fungoides-like presentations of DUSP22-translocated T-cell lymphomas. |
IRF4 |
| 6 |
34705295 |
10.1111/cup.14157 |
2022 |
Primary cutaneous anaplastic large-cell lymphoma with aberrant cytokeratin expression: An unusual mimicker of poorly differentiated carcinomas. |
IRF4 |
| 7 |
34775495 |
10.1038/s41374-021-00638-x |
2022 |
microRNA-155-5p initiates childhood acute lymphoblastic leukemia by regulating the IRF4/CDK6/CBL axis. |
IRF4 |
| 8 |
34791573 |
10.1007/s10014-021-00415-0 |
2022 |
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement. |
IRF4 |
| 9 |
34801601 |
10.1016/j.humpath.2021.11.007 |
2022 |
Clinicopathological features of syncytial variant nodular sclerosis Hodgkin lymphoma. |
IRF4 |
| 10 |
34913532 |
10.1002/pro.4260 |
2022 |
The molecular basis for the development of adult T-cell leukemia/lymphoma in patients with an IRF4<sup>K59R</sup> mutation. |
IRF4 |
| 11 |
34952945 |
10.1038/s41379-021-01002-6 |
2022 |
Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue. |
IRF4 |
| 12 |
35001425 |
10.1111/cup.14199 |
2022 |
Primary cutaneous CD8+ cytotoxic T-cell lymphoma of the face with intraoral involvement, resulting in facial nerve palsy after chemotherapy. |
IRF4 |
| 13 |
35030632 |
10.1182/bloodadvances.2021006410 |
2022 |
Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients. |
IRF4 |
| 14 |
35142151 |
10.3324/haematol.2021.279908 |
2022 |
A pilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas. |
IRF4 |
| 15 |
35183824 |
10.1016/j.prp.2022.153804 |
2022 |
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma. |
IRF4 |
| 16 |
35255429 |
10.1016/j.anndiagpath.2021.151886 |
2022 |
De Novo CD5-positive diffuse large B-cell lymphoma: A genomic profiling study and prognostic analysis of 46 patients. |
IRF4 |
| 17 |
35411950 |
10.1002/cbf.3702 |
2022 |
USP7 sustains an active epigenetic program via stabilizing MLL2 and WDR5 in diffuse large B-cell lymphoma. |
IRF4 |
| 18 |
35472072 |
10.1371/journal.ppat.1010453 |
2022 |
Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells. |
IRF4 |
| 19 |
35675522 |
10.1182/bloodadvances.2022007725 |
2022 |
ETS1 is a novel transcriptional regulator of adult T-cell leukemia/lymphoma of North American descent. |
IRF4 |
| 20 |
35759728 |
10.1182/blood.2022015926 |
2022 |
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma. |
IRF4 |
| 21 |
35884496 |
10.3390/cancers14143434 |
2022 |
Classifying Germinal Center Derived Lymphomas-Navigate a Complex Transcriptional Landscape. |
IRF4 |
| 22 |
35884913 |
10.3390/biomedicines10071608 |
2022 |
Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma. |
IRF4 |
| 23 |
35928872 |
10.3389/fonc.2022.932674 |
2022 |
Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma. |
IRF4 |
| 24 |
35968590 |
10.3760/cma.j.issn.0253-2727.2022.06.006 |
2022 |
[Large B-cell lymphoma with IRF4 rearrangement: six case reports and a literature review]. |
IRF4 |
| 25 |
35983077 |
10.1155/2022/9544827 |
2022 |
Immunogenomic-Based Analysis of Hierarchical Clustering of Diffuse Large Cell Lymphoma. |
IRF4 |
| 26 |
35984488 |
10.1007/s00428-022-03385-6 |
2022 |
Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma. |
IRF4 |
| 27 |
36009586 |
10.3390/biomedicines10082038 |
2022 |
Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma. |
IRF4 |
| 28 |
36047964 |
10.1111/cas.15550 |
2022 |
Alvocidib inhibits IRF4 expression via super-enhancer suppression and adult T-cell leukemia/lymphoma cell growth. |
IRF4 |
| 29 |
32139889 |
10.1038/s41375-020-0766-4 |
2021 |
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL. |
IRF4 |
| 30 |
32749698 |
10.1002/jcp.29953 |
2021 |
Roles of BATF/JUN/IRF4 complex in tacrolimus mediated immunosuppression on Tfh cells in acute rejection after liver transplantation. |
IRF4 |
| 31 |
33150420 |
10.1182/blood.2020005083 |
2021 |
Plasmablasts derive from CD23- activated B cells after the extinction of IL-4/STAT6 signaling and IRF4 induction. |
IRF4 |
| 32 |
33411730 |
10.1371/journal.ppat.1009091 |
2021 |
Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2. |
IRF4 |
| 33 |
33503299 |
10.1111/pin.13067 |
2021 |
B cell lymphoma with IRF4 rearrangement: A clinicopathological study of 13 cases. |
IRF4 |
| 34 |
33512466 |
10.1182/blood.2020010175 |
2021 |
OBF1 and Oct factors control the germinal center transcriptional program. |
IRF4 |
| 35 |
33597573 |
10.1038/s41598-021-83352-4 |
2021 |
Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma. |
IRF4 |
| 36 |
33629212 |
10.1007/s12032-021-01470-5 |
2021 |
Identification BCL6 and miR-30 family associating with Ibrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma. |
IRF4 |
| 37 |
33654205 |
10.1038/s41375-021-01181-w |
2021 |
BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma. |
IRF4 |
| 38 |
33685720 |
10.1016/j.pathol.2021.01.002 |
2021 |
New developments in non-Hodgkin lymphoid malignancies. |
IRF4 |
| 39 |
33777778 |
10.3389/fonc.2021.628807 |
2021 |
Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma. |
IRF4 |
| 40 |
34078047 |
10.3760/cma.j.cn112151-20210204-00127 |
2021 |
[Clinicopathological and molecular genetic features of Burkitt-like lymphoma with 11q aberration]. |
IRF4 |
| 41 |
34304770 |
10.1016/j.cll.2021.03.018 |
2021 |
Update on Pediatric and Young Adult Mature Lymphomas. |
IRF4 |
| 42 |
34455369 |
10.1016/j.bbrc.2021.08.051 |
2021 |
Involvement of EZH2 inhibition in lenalidomide and pomalidomide-mediated growth suppression in HTLV-1-infected cells. |
IRF4 |
| 43 |
34465776 |
10.1038/s41467-021-25405-w |
2021 |
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma. |
IRF4 |
| 44 |
34477080 |
NA |
2021 |
Indurated Plaques on the Legs: Think Lymphoma. |
IRF4 |
| 45 |
34707037 |
10.3960/jslrt.21025 |
2021 |
t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma. |
IRF4 |
| 46 |
31361906 |
10.1111/his.13964 |
2020 |
Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area. |
IRF4 |
| 47 |
31631721 |
10.1177/1066896919883013 |
2020 |
Primary Low-Grade B-Cell Lymphoma of Skull With Translocation Between Immunoglobulin and Interferon Regulatory Factor 4 Genes. |
IRF4 |
| 48 |
31688142 |
10.1097/PAS.0000000000001399 |
2020 |
Unusual Variants of Follicular Lymphoma: Case-based Review. |
IRF4 |
| 49 |
31735345 |
10.1016/j.pathol.2019.08.013 |
2020 |
Diffuse large B-cell lymphoma variants: an update. |
IRF4 |
| 50 |
31738823 |
10.1182/blood.2019002699 |
2020 |
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. |
IRF4 |
| 51 |
31773249 |
10.1007/s00428-019-02704-8 |
2020 |
Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas. |
IRF4 |
| 52 |
31882178 |
10.1053/j.semdp.2019.12.002 |
2020 |
Pathology and genetics of anaplastic large cell lymphoma. |
IRF4 |
| 53 |
31914056 |
10.1097/MD.0000000000018670 |
2020 |
Clinicopathologic features and prognostic analysis of Waldeyer ring B-cell lymphoma. |
IRF4 |
| 54 |
31964683 |
10.1136/jclinpath-2019-206267 |
2020 |
Application of 2016 WHO classification in the diagnosis of paediatric high-grade <i>MYC</i>-negative mature B-cell lymphoma with Burkitt-like morphological features. |
IRF4 |
| 55 |
31972002 |
10.1182/blood.2019002639 |
2020 |
Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma. |
IRF4 |
| 56 |
32100965 |
10.1111/ddg.14041 |
2020 |
Lymphomatoid papulosis. |
IRF4 |
| 57 |
32202225 |
10.1177/0300985820913265 |
2020 |
Spectrum of Posttransplant Lymphoproliferations in NSG Mice and Their Association With EBV Infection After Engraftment of Pediatric Solid Tumors. |
IRF4 |
| 58 |
32239385 |
10.1007/s11523-020-00710-4 |
2020 |
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib. |
IRF4 |
| 59 |
32239695 |
10.1111/bjh.16578 |
2020 |
Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. |
IRF4 |
| 60 |
32585984 |
10.3390/cancers12061669 |
2020 |
Discovery of Novel Recurrent Mutations and Clinically Meaningful Subgroups in Nodal Marginal Zone Lymphoma. |
IRF4 |
| 61 |
32753663 |
10.1038/s41598-020-69884-1 |
2020 |
Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma. |
IRF4 |
| 62 |
32771332 |
10.1016/j.oraloncology.2020.104910 |
2020 |
Primary intraosseous CD9-positive B-cell lymphoblastic lymphoma of the maxilla affecting a pediatric patient: Immunohistochemical and in situ hybridization analysis. |
IRF4 |
| 63 |
32779615 |
10.3960/jslrt.20019 |
2020 |
Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma. |
IRF4 |
| 64 |
32817485 |
10.1073/pnas.1922216117 |
2020 |
Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional <i>MYC</i> superenhancers and enhancer RNAs. |
IRF4 |
| 65 |
32843547 |
10.1128/mBio.01457-20 |
2020 |
Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma. |
IRF4 |
| 66 |
32859220 |
10.1186/s12977-020-00535-z |
2020 |
Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma. |
IRF4 |
| 67 |
32889849 |
10.1097/QAD.0000000000002590 |
2020 |
HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients. |
IRF4 |
| 68 |
32909092 |
10.1007/s00292-020-00816-6 |
2020 |
[Fluorescence in situ hybridization in the diagnosis of aggressive B-cell lymphomas]. |
IRF4 |
| 69 |
32914098 |
10.1158/2643-3230.BCD-20-0009 |
2020 |
Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma. |
IRF4 |
| 70 |
32921221 |
10.1080/10428194.2020.1815017 |
2020 |
Clinicopathological and prognostic significance of <i>BCL2</i>, <i>BCL6</i>, <i>MYC</i>, and <i>IRF4</i> copy number gains and translocations in follicular lymphoma: a study by FISH analysis. |
IRF4 |
| 71 |
32922661 |
10.18632/oncotarget.27683 |
2020 |
The NKL-code for innate lymphoid cells reveals deregulated expression of NKL homeobox genes HHEX and HLX in anaplastic large cell lymphoma (ALCL). |
IRF4 |
| 72 |
32992413 |
10.3760/cma.j.cn112151-20200601-00433 |
2020 |
[Clinicopathological study of large B-cell lymphoma with IRF4 rearrangement]. |
IRF4 |
| 73 |
33017467 |
10.1182/bloodadvances.2020002049 |
2020 |
The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1. |
IRF4 |
| 74 |
33298918 |
10.1038/s41467-020-20136-w |
2020 |
Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors. |
IRF4 |
| 75 |
33357426 |
10.1016/j.celrep.2020.108517 |
2020 |
Chromatin Protein PC4 Orchestrates B Cell Differentiation by Collaborating with IKAROS and IRF4. |
IRF4 |
| 76 |
30019203 |
10.1007/s00292-018-0456-4 |
2019 |
[Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?] |
IRF4 |
| 77 |
30380402 |
10.1016/j.anndiagpath.2018.09.014 |
2019 |
Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues. |
IRF4 |
| 78 |
30664244 |
10.1002/eji.201847855 |
2019 |
Transformation of mature mouse B cells into malignant plasma cells in vitro via introduction of defined genetic elements. |
IRF4 |
| 79 |
30695866 |
10.3760/cma.j.issn.0529-5807.2019.02.011 |
2019 |
[Clinicopathological features of follicular lymphoma in children]. |
IRF4 |
| 80 |
30732171 |
10.1097/MD.0000000000014367 |
2019 |
Diffuse large B-cell lymphoma of the central nervous system presenting as lymphomatosis cerebri and dementia in elderly man: Case report and review of the literature. |
IRF4 |
| 81 |
30792929 |
10.1155/2019/3730915 |
2019 |
CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type. |
IRF4 |
| 82 |
30802809 |
10.1016/j.anndiagpath.2019.02.001 |
2019 |
American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma. |
IRF4 |
| 83 |
30907723 |
10.1099/jgv.0.001249 |
2019 |
IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells. |
IRF4 |
| 84 |
30962205 |
10.1182/blood.2018880138 |
2019 |
Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells. |
IRF4 |
| 85 |
31012208 |
10.1002/pbc.27770 |
2019 |
IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials. |
IRF4 |
| 86 |
31039827 |
10.1186/s13073-019-0637-7 |
2019 |
A modular transcriptome map of mature B cell lymphomas. |
IRF4 |
| 87 |
31102405 |
10.1093/neuonc/noz088 |
2019 |
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study. |
IRF4 |
| 88 |
31104675 |
10.3760/cma.j.issn.0529-5807.2019.05.006 |
2019 |
[Clinicopathological features and molecular genetics of paediatric-type follicular lymphoma: report of eight cases]. |
IRF4 |
| 89 |
31187530 |
10.1002/hon.2585 |
2019 |
Rare mature B-cell lymphomas in children and adolescents. |
IRF4 |
| 90 |
31278738 |
10.1093/ajcp/aqz078 |
2019 |
Molecular Genetics in the Diagnosis and Biology of Lymphoid Neoplasms. |
IRF4 |
| 91 |
31292115 |
10.1182/blood.2019001126 |
2019 |
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. |
IRF4 |
| 92 |
31331250 |
10.2217/pme-2018-0068 |
2019 |
Bioinformatic validation identifies candidate key genes in diffuse large-B cell lymphoma. |
IRF4 |
| 93 |
31363108 |
10.1038/s41598-019-47343-w |
2019 |
A bioinformatic analysis identifies circadian expression of splicing factors and time-dependent alternative splicing events in the HD-MY-Z cell line. |
IRF4 |
| 94 |
31584842 |
10.5858/arpa.2019-0331-RA |
2019 |
Ancillary Studies in the Diagnostic Evaluation of Large B-Cell Lymphoma. |
IRF4 |
| 95 |
31594013 |
10.1055/a-0597-7606 |
2019 |
[Current standard in diagnostic and therapy of peripheral T-cell lymphoma]. |
IRF4 |
| 96 |
31837029 |
10.1111/vcp.12816 |
2019 |
Lymphoma with Mott cell differentiation and validation of immunohistochemical lymphoid markers in an African pygmy hedgehog (Atelerix albiventris). |
IRF4 |
| 97 |
29084771 |
10.1182/blood-2017-01-761874 |
2018 |
Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma. |
IRF4 |
| 98 |
29097500 |
10.3324/haematol.2017.179309 |
2018 |
A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma. |
IRF4 |
| 99 |
29122756 |
10.1182/blood-2017-08-799080 |
2018 |
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy. |
IRF4 |
| 100 |
29154209 |
10.1016/j.molimm.2017.11.011 |
2018 |
External signals regulate germinal center fate-determining transcription factors in the A20 lymphoma cell line. |
IRF4 |
Datasets
Models
